Literature DB >> 25654205

Radiation doses from fluoroscopically guided cardiac catheterization procedures in children and young adults in the United Kingdom: a multicentre study.

R W Harbron1, M S Pearce, J A Salotti, K McHugh, C McLaren, L Abernethy, S Reed, J O'Sullivan, C-L Chapple.   

Abstract

OBJECTIVE: To gather data on radiation doses from fluoroscopically guided cardiac catheterization procedures in patients aged under 22 years at multiple centres and over a prolonged period in the UK. To evaluate and explain variation in doses. To estimate patient-specific organ doses and allow for possible future epidemiological analysis of associated cancer risks.
METHODS: Patient-specific data including kerma area product and screening times from 10,257 procedures carried out on 7726 patients at 3 UK hospitals from 1994 until 2013 were collected. Organ doses were estimated from these data using a dedicated dosimetry system based on Monte Carlo computer simulations.
RESULTS: Radiation doses from these procedures have fallen significantly over the past two decades. The organs receiving the highest doses per procedure were the lungs (median across whole cohort, 20.5 mSv), heart (19.7 mSv) and breasts (13.1 mSv). Median cumulative doses, taking into account multiple procedures, were 23.2, 22.2 and 16.7 mSv for these organs, respectively. Bone marrow doses were relatively low (median per procedure, 3.2 mSv; cumulative, 3.6 mSv).
CONCLUSION: Most modern cardiac catheterizations in children are moderately low-dose procedures. Technological advances appear to be the single most important factor in the fall in doses. Patients undergoing heart transplants undergo the most procedures. An epidemiological assessment of cancer risks following these procedures may be possible, especially using older data when doses were higher. ADVANCES IN KNOWLEDGE: This is the first large-scale, patient-specific assessment of organ doses from these procedures in a young population.

Entities:  

Mesh:

Year:  2015        PMID: 25654205     DOI: 10.1259/bjr.20140852

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

Review 1.  Update on the Role of Cardiac Magnetic Resonance Imaging in Congenital Heart Disease.

Authors:  Prabhakar Rajiah; Animesh Tandon; Gerald F Greil; Suhny Abbara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

2.  Assessment of PCXMC for patients with different body size in chest and abdominal x ray examinations: a Monte Carlo simulation study.

Authors:  David Borrego; Erin M Lowe; Cari M Kitahara; Choonsik Lee
Journal:  Phys Med Biol       Date:  2018-03-21       Impact factor: 3.609

3.  Percutaneous closure of ventricular septal defects in children: key parameters affecting patient radiation exposure.

Authors:  Raymond N Haddad; Chadia Rizk; Zakhia Saliba; Jad Farah
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

Review 4.  Radiation Exposure in Pediatric Interventional Procedures.

Authors:  Agapi Ploussi; Elias Brountzos; Spyridon Rammos; Sotiria Apostolopoulou; Efstathios P Efstathopoulos
Journal:  Cardiovasc Intervent Radiol       Date:  2021-05-19       Impact factor: 2.740

5.  Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children.

Authors:  Richard W Harbron; Claire-Louise Chapple; John J O'Sullivan; Kate E Best; Amy Berrington de González; Mark S Pearce
Journal:  Heart       Date:  2016-08-18       Impact factor: 5.994

Review 6.  Recent advances in cardiac catheterization for congenital heart disease.

Authors:  Sok-Leng Kang; Lee Benson
Journal:  F1000Res       Date:  2018-03-26

7.  Increased Cancer Incidence Following up to 15 Years after Cardiac Catheterization in Infants under One Year between 1980 and 1998-A Single Center Observational Study.

Authors:  Heiko Stern; Michael Seidenbusch; Alexander Hapfelmeier; Christian Meierhofer; Susanne Naumann; Irene Schmid; Claudia Spix; Peter Ewert
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.